In Conversation

There is a segment of people looking to take better care of their immune systems through healthy food, preventive measures, supplements, vitamins, and physical activity. Within…

We have set some goals not only as an industry but as a country: increase the production of high-value products not only in pharma but across…

The enthusiasm for our device comes from its simplicity paired with the many new functions. I often compare it to a smartphone which is very easy…

Singapore has always been considered the bellwether of driving innovation in the region, which remains the case. In terms of new oncology and immunology products, Singapore…

Our industry is a cornerstone of Saudi Vision because we are making big investments in talent development alongside the public sector to ensure that we raise…

It is important to look at healthcare as an investment, rather than a burden on the public budget: an investment in the population, their health and…

The talent in Saudi Arabia is absolutely world-class; they are highly educated and extremely hard-working. They have a high sense of purpose, and are very engaged.…

The biggest opportunity [in MEA] is to help accelerate the diagnosis and treatment of patients, too many of whom fall through the gaps of healthcare coverage…

Our venture capital arm has a strategic focus which means that our main interest is not the mere financial return on investment but rather helping companies…

The ambitious mindset that the Saudi Arabia Vision 2030 sets out fits well with the mentality we are embracing at Novartis. I like to say that…

[R&D] is the gateway to successful production and competition in the marketplace. Without R&D, DEVA would not be where it is today

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here